Evidence map›Paper›PMID 28427151›Full record

ReviewOncotarget2017

Fine tuning of vitamin D receptor (VDR) activity by post-transcriptional and post-translational modifications.

Ondrej Zenata, Radim Vrzal

Open access · diamondAbstract readReview
In one paragraph

Review in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. The Association ofAnalytical cellular pathology (Amsterdam) · 2025
    Article
  8. Observational
  9. Article
  10. Vitamin D Receptor Regulates the Expression of the Grainyhead-Like 1 Gene.International journal of molecular sciences · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Assessment of the contribution ofJournal of genetics · 2024
    Article
  15. Review
  16. Article
  17. Review
  18. Supplementation with Vitamin DInternational journal of molecular sciences · 2023
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ondrej ZenataDepartment of Cell Biology and Genetics, Faculty of Science, Palacky University, Olomouc, Czech Republic.
Radim VrzalDepartment of Cell Biology and Genetics, Faculty of Science, Palacky University, Olomouc, Czech Republic.
Palacký University Olomouc · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitamin D receptor (VDR) is a member of the nuclear receptor (NR) superfamily of ligand-activated transcription factors. Activated VDR is responsible for maintaining calcium and phosphate homeostasis, and is required for proper cellular growth, cell differentiation and apoptosis. The expression of both phases I and II drug-metabolizing enzymes is also regulated by VDR, therefore it is clinically important.Post-translational modifications of NRs have been known as an important mechanism modulating the activity of NRs and their ability to drive the expression of target genes. The aim of this mini review is to summarize the current knowledge about post-transcriptional and post-translational modifications of VDR.

Indexed as

Protein Processing, Post-TranslationalGene Expression RegulationHumansMicroRNAsPhosphorylationReceptors, CalcitriolSumoylationTranscription, GeneticUbiquitinationMicroRNAsMIRN125 microRNA, humanMIRN27 microRNA, humanReceptors, CalcitriolVDR protein, humanmiRNAphosphorylation, ubiquitination, sumoylation, VDRB1, VDRA

Identifiers

PMID28427151
PMCPMC5471063
OpenAlexW2591336302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.